All

IDnow acquires Wirecard Communication Services
1 September 2020

IDnow acquires Wirecard Communication Services

IDnow, a leading provider of Identity Verification-as-a-Service solutions and Wirecard Communication Services GmbH announce the signing of an agreement for the acquisition of...

Read more
IZICAP JOINS MASTERCARD START PATH STARTUP ENGAGEMENT PROGRAM
27 August 2020

IZICAP JOINS MASTERCARD START PATH STARTUP ENGAGEMENT PROGRAM

IZICAP, the European leader of card-linked CRM & Loyalty platform dedicated to local merchants, is supported by Mastercard in its scaling strategy.

Read more
Seventure’s Health for Life Capital II™ fund qualifies for French government’s financing initiative (“TIBI”) as first and only fund in the microbiome field
30 July 2020

Seventure’s Health for Life Capital II™ fund qualifies for French government’s financing initiative (“TIBI”) as first and only fund in the microbiome field

Seventure Partners, a European leader in financing innovation, announces today that the technical committee of the French government initiative, which was set up to support...

Read the press release
Enterome initiates first clinical trial with EO2401 – an innovative microbiomeantigen based cancer immunotherapy candidate targeting aggressive brain cancer
30 July 2020

Enterome initiates first clinical trial with EO2401 – an innovative microbiomeantigen based cancer immunotherapy candidate targeting aggressive brain cancer

ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the microbiome-immunoinflammation axis to develop next-generation therapeutics,...

Read the press release
Clim8 raises €2.75m Series A funding
27 July 2020

Clim8 raises €2.75m Series A funding

The French company, founded in 2016, is a leader in the connected textiles market with its intelligent and patented thermal technologies. With more than 50% of its sales...

Read the press release
Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates
21 July 2020

Tubulis Raises €10.7 M Series A to Advance Development of a New Generation of Antibody-Drug Conjugates

Tubulis announced the close of a €10.7 million Series A financing round to accelerate the development of a new class of highly stable and efficient antibody-drug conjugates...

Read the press release
Citryll completes € 18.5 M fundraise to develop CIT-013, an antibody targeting Neutrophil Extracellular Traps
2 July 2020

Citryll completes € 18.5 M fundraise to develop CIT-013, an antibody targeting Neutrophil Extracellular Traps

OSS, Netherlands-Citryll announced it closed a total fundraise of € 18.5 million, led by Seventure (including their Health for Life Capital II fund), co-led by BioGeneration...

Read more
Transfergo raises $10M additional funding, launches in 11 new markets
16 June 2020

Transfergo raises $10M additional funding, launches in 11 new markets

TransferGo, the London-based international money transfer service, has raised another $10 million in funding, as it discloses that its customer numbers have surpassed two...

Read more
CARB-X FUNDS ELIGO BIOSCIENCE TO DEVELOP CRISPR-BASED THERAPEUTICS DERIVED FROM BACTERIOPHAGES TO KILL SUPERBUGS AND PREVENT DEADLY INFECTIONS IN TRANSPLANT PATIENTS
2 July 2020

CARB-X FUNDS ELIGO BIOSCIENCE TO DEVELOP CRISPR-BASED THERAPEUTICS DERIVED FROM BACTERIOPHAGES TO KILL SUPERBUGS AND PREVENT DEADLY INFECTIONS IN TRANSPLANT PATIENTS

(BOSTON) – CARB-X announced today that it is awarding up to US$1.82 million to Eligo Bioscience in Paris, France, with additional funding for a total award of up to US$7.05...

Read more
Enterome completes €46.3 million ($52.6 million) financing to progress the clinical development of its therapeutic pipeline
25 June 2020

Enterome completes €46.3 million ($52.6 million) financing to progress the clinical development of its therapeutic pipeline

ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge of the microbiome-immunoinflammation axis to develop next-generation therapeutics, today...

Read the press release